Wei Gao

Education

Ph.D., biostatistics, Boston University; M.S., biostatistics, The George Washington University; B.S., mathematics, Fudan University

Summary of Experience

Dr. Gao specializes in developing innovative statistical methodologies and applying them to the study of clinical and economic outcomes in a broad range of disease areas. He has led and implemented analyses across entire product lifecycles, from early-phase clinical trials to post-market real-world evidence generation. Dr. Gao has particular expertise in retrospective data and clinical trial data analysis, health economics modeling, indirect treatment comparisons, predictive analytics, meta-analyses, individualized medicine, and statistical genetics. His research has supported the launches of several pharmaceutical products and has been widely published in leading peer-reviewed journals, including The New England Journal of Medicine, JAMA, Nature Genetics, Nature Communications, and the American Journal of Respiratory and Critical Care Medicine. He has presented his work at multiple statistical and health care conferences.

Selected Publishing

• Integrating real-world data and modeling to project changes in femoral neck bone mineral density and fracture risk in premenopausal women

  Clinical and Translational Science, 2021
  2021

  Beck D, Winzenborg I, Gao W, Mostafa NM, Noertersheuser P, Chiuve SE, Owens C, Shebley M

  Health Care
• Real-world Clinical Outcomes of Pazopanib Immediately After Discontinuation of Immunotherapy for Advanced Renal Cell Carcinoma

  Clinical Genitourinary Cancer, 2020
  2020

  Cao X, Tang D, Ratto B, Poole A, Ravichandran S, Jin L, Gao W, Swallow E, Vogelzang NJ

  Health Care
• An Economic Evaluation of Pembrolizumab Versus Other Adjuvant Treatment Strategies for Resected High-Risk Stage III Melanoma in the USA

  Clinical Drug Investigation, 2020
  2020

  Bensimon AG, Zhou ZY, Jenkins M, Song Y, Gao W, Signorovitch J, Krepler C, Scherrer E, Wang J, Aguiar-Ibáñez R

  Health Care
• Estimating the Effect of Elagolix Treatment for Endometriosis on Postmenopausal Bone Outcomes: A Model Bridging Phase III Trials to an Older Real-World Population

  JBMR Plus, 2020
  2020

  Kilpatrick RD, Chiuve SE, Leslie WD, Wegrzyn LR, Gao W, Yang H, Soliman AM, Snabes MC, Koenigsberg S, Zhong J, Xiang C, Watts NB

  Health Care
• Prevalence of chronic respiratory morbidity, length of stay, inpatient readmissions, and costs among extremely preterm infants with bronchopulmonary dysplasia

  Expert Review of Pharmacoeconomics & Outcomes Research, 2020
  2020

  Mowitz ME, Mangili A, Han L, Ayyagari R, Gao W, Wang J, Zhao J, Sarda SP

  Health Care
• Cost-effectiveness of olaparib as a maintenance treatment for women with newly diagnosed advanced ovarian cancer and BRCA1/2 mutations in the United States

  Gynecologic Oncology, 2020
  2020

  Muston D, Hettle R, Monberg M, McLaurin KK, Gao W, Swallow E, Zhang S, Kalemaj I, Signorovitch J, Moore K

  Health Care
• A Critical Appraisal and Recommendations for Cost-Effectiveness Studies of Poly(ADP-Ribose) Polymerase Inhibitors in Advanced Ovarian Cancer

  Pharmacoeconomics, 2020
  2020

  Gao W, Muston D, Monberg M, McLaurin K, Hettle R, Szamreta E, Swallow E, Zhang S, Kalemaj I, Signorovitch J, McQueen RB

  Health Care
• Real-world healthcare resource utilization related to migraine treatment failure: a panel-based chart review in France, Germany, Italy, and Spain

  Journal of Medical Economics, 2019
  2019

  Vo P, Gao W, Zichlin ML, Fuqua E, Fadli E, Vazquez MA, Tarancón T, Mahieu N, Maier-Peuschel M, Rossi S, Naclerio M, Ritrovato D, Swallow E

  Health Care
• Migraine-related healthcare resource use in the emergency department setting: a panel-based chart review in France, Germany, Italy, and Spain

  Journal of Medical Economics, 2019
  2019

  Vo P, Gao W, Zichlin ML, Fuqua E, Fadli E, Vazquez MA, Tarancón T, Mahieu N, Maier-Peuschel M, Rossi S, Naclerio M, Ritrovato D, Swallow E

  Health Care
• Matching-Adjusted Indirect Comparison of Blinatumomab vs. Inotuzumab Ozogamicin for Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia

  Advances in Therapy, 2019
  2019

  Song J, Ma Q, Gao W, Cong Z, Xie J, Zimmerman Z, Belton L, Franklin J, Palmer S

  Health Care
• Health Care Burden of Bronchopulmonary Dysplasia Among Extremely Preterm Infants

  Frontiers in Pediatrics, 2019
  2019

  Mowitz ME, Ayyagari R, Gao W, Zhao J, Mangili A, Sarda SP

  Health Care
• Cost-effectiveness of pembrolizumab for the adjuvant treatment of resected high-risk stage III melanoma in the United States

  Journal of Medical Economics, 2019
  2019

  Bensimon AG, Zhou ZY, Jenkins M, Song Y, Gao W, Signorovitch J, Krepler C, Liu FX, Wang J, Aguiar-Ibáñez R

  Health Care
• Matching-adjusted indirect comparisons of annualized bleeding rate and utilization of BAY 94-9027 versus three recombinant factor VIII agents for prophylaxis in patients with severe hemophilia A

  Journal of Blood Medicine, 2019
  2019

  Batt K, Gao W, Ayyagari R, Deschaseaux C, Vashi PB, Yao Z, Wang Y, Kessabi S, Klamroth R

  Health Care

News

• June 4, 2021

  2021 ASCO Annual Meeting to Feature New Outcomes Research from Analysis Group

  Health Care
• October 22, 2019

  Analysis Group Health Care Consultants Present at ISPOR Europe 2019

  Health Care